Tychos Therapeutics Private Limited, a active private limited company, was established on 15 December 2003 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U51397TN2003PTC052144. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹3.60 M and a paid-up capital of ₹3.60 M.
It upholds a compliant status. Employing 12 professional, Its leadership includes Maniyan Elangovan (Managing Director), Sunitha Nagarajan (Director). Past directors included Nagarajan Karthik, Anbazhagan Durairajan, Vasantha Durairasan. It holds ₹6.88 Cr open charges and ₹3.70 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Dp136-Sidco Industrial Estate Thirumudivakkam,, Chennai, Tamil Nadu, 600044.
U51397TN2003PTC052144
052144
15 December 2003
₹3.60 M
₹3.60 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Tychos Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Maniyan Elangovan | Managing Director | 15 Dec 2003 | Current |
| Sunitha Nagarajan | Director | 04 Mar 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Mar 2013 | Past |
| Pramod Abcsdd | Director | 12 Nov 2009 | Past |
| Pramod Abcsdd | Director | 12 Nov 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Tychos Therapeutics Private Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 4.43% decrease. The company also saw a slight improvement in profitability, with a 7.8% increase in profit. The company's net worth Soared by an impressive increase of 10.53%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Tychos Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹68,795,000.00
₹37,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jul 2025 | Sidbi | ₹3.15 Cr | Open |
| 20 Apr 2022 | Others | ₹1.50 Cr | Open |
| 02 Mar 2016 | Hdfc Bank Limited | ₹2.23 Cr | Open |
| 07 Sep 2013 | Axis Bank Limited | ₹1.50 Cr | Satisfied |
| 25 Feb 2005 | City Union Bank Limited | ₹2.20 Cr | Satisfied |
Explore comprehensive loan charge details -
Tychos Therapeutics has a workforce of 12 employees as of Mar 07, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Tychos Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tychos Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others of Rs. 14.98 M registered on 20 Apr 2022 with Charge ID 100593472 was modified on 29 Nov 2025. was documented.
The activity A charge with Sidbi amounted to Rs. 31.52 M with Charge ID 101125353 was registered on 21 Jul 2025. was completed.
Progress on Tychos Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Tychos Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was completed.
Progress on A charge with Hdfc Bank Limited of Rs. 22.30 M registered on 02 Mar 2016 with Charge ID 100022735 was modified on 08 May 2022. was documented.
The activity A charge with Others amounted to Rs. 14.98 M with Charge ID 100593472 was registered on 20 Apr 2022. was completed.
The CIN of Tychos Therapeutics Private Limited is U51397TN2003PTC052144.
Tychos Therapeutics Private Limited is headquartered at Dp136-Sidco Industrial Estate Thirumudivakkam,, Chennai, Tamil Nadu, 600044.
Tychos Therapeutics Private Limited was incorporated on 15 December 2003.
The current directors of Tychos Therapeutics Private Limited are
The primary industry of Tychos Therapeutics Private Limited is Manufacturing.
Tychos Therapeutics Private Limited is unlisted.
The authorized capital of Tychos Therapeutics Private Limited is ₹3.60 M, and the paid-up capital is ₹3.60 M.
The compliance status of Tychos Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX